Grateful to @lpbadano for invitation to write https://t.co/kEgGtrct4A Together w/ @denisamuraru @pe_bartko @drmaisano Pepe Zamorano and @DonalErwan @ESC_Journals @EACVIPresident @escardio @ASE360 @iamritu @GilbertTangMD @ACCinTouch @HeartValveCntr @GeraldMaurer

In Low Gradient AS, reduced GLS, increased ECV and LGE on CMR was associated with worse outcomes. Comprehensive myocardial characterization using cardiac magnetic resonance associates with outcomes in low gradient severe aortic stenosis https://t.co/t7CMtMX7af

New multicenter TOPAS CMR study led by @Miho_Fukui_ and @PPibarot demonstrates the importance of phenotyping myocardial structural and function using #whyCMR in the complex group of low-gradient AS. Prognosis worsens with greater # of CMR risk markers. https://t.co/jHXKMfi8Mh

Join @EdwardsLifesci in Paris or online for their #EuroPCR 2022 symposiums: ➡️"Valve in Valve and the journey starting with the first prosthesis" with @ValveDisease on May 17th ➡️"Learnings from an optimised #TAVI patient's journey" on May 18th Sponsored post by @EdwardsLifesci

Im Rahmen der Langen Nacht der Forschung können Sie eine von unseren @KardiologieWien ExpertInnen live-kommentierte minimal-invasive Herklappen-Implantation verfolgen! Fr 20.5. 18:00 @MedUni_Wien / AKH Hörsaalzentrum https://t.co/dHo4L9skJd

GDMT titration conveys 3x higher chance to achieve improvement in secondary MR. 40% pts achieved #SMR reduction w/ ARNi and combinations of RASi, BB & MRA Congrats @pe_bartko @ggoliasch https://t.co/SqYhf79AwJ #EHJCVI @ESC_Journals @GeraldMaurer

Tricuspid regurgitation: what have we learnt? #EHJCVI 🚩 New nomenclature 🚩 New classification 🚩 New grading 🚩 New imaging approaches https://t.co/Tgcwilsurg Fantastic leadership by @hahn_rt &collaboration @lpbadano @drmaisano @pe_bartko @DonalErwan JL Zamorano #PCRTricuspid

Thank you to my co-authors @lpbadano @denisamuraru @pe_bartko @drmaisano @PEPEZAMORANO and @DonalErwan: TR Review https://t.co/l1dGh8YI7g @ESC_Journals @escardio @ASE360 @echo_stepbystep @EGarciaSayan @robertomlang

Excited to announce that my new provocative maneuver to detect PFO using party balloon during Saline Contrast Transthoracic Echocardiography has been published in JACC: Case Reports. https://t.co/iUdmGljWHF

Topological mapping in secondary MR (sMR): #echofirst analysis shows importance of role of LA. Highest mortality in “small LV cavity” cluster. https://t.co/p71Eta3txG #vhdMR #cvVHD #JACCIMG #CardioTwitter #cvImaging #HFrEF @ValveDisease @pe_bartko @g_heitzinger @ggoliasch

What are the key morphological and functional features in secondary mitral regurgitation? @pe_bartko, @g_heitzinger, @ggoliasch et al from our @ValveDisease group present exciting novel data in @JACCJournals https://t.co/JZG0CROvaB

"Unsupervised clustering supports the association of sMR with mortality predominantly driven by the small LV cavity phenotype, as previously suggested by a conceptional framework and termed disproportionate sMR" https://t.co/Y1lbepWAT8

The association of secondary MR with mortality cannot be purely attributed to cardiac morphology alone. From @jaccjournals https://t.co/zHbVWmYeem

Ever thought of preventing aortic stenosis (AS) instead having AVR or TAVI? Molecular mechanisms are unravelled and we will prevent AS like CAD. Statins do not work, but Lp(a) is a target in some, in others molecular mechanisms are deciphered - read it in the EHJ online!

Stress FR during LDDSE is useful for the detection of AS severity & flow reserve & is associated with outcomes following aortic valve intervention @AVamvakidou @PPibarot @E_Guzzetti @pe_bartko @orwi @JoaoLCavalcante @BerglerKlein @cshenoy3 #AHAJournals https://t.co/TKGEXDR7j3

In anticipation of #ASE21 this weekend, we'd like to share this AI on #EchoFirst. This frame-to-frame measurement of PLAX was fully automated by EchoNet-LVH. More examples and preprint soon! @ASE360 @CedarsSinai

First come first serve for #euroecho on-site in Berlin. Limited number of seats. #eacvi This is one get his inscription! @escardio @alessia_gimelli @denisamuraru @Matte_Cameli @s_e_petersen @ThorEdvardsen @MarcDweck @JGrapsa @EACVIPresident

Each 5mmHg reduction in systolic blood pressure lowered the relative risk of cardiovascular events by around 10%. Authors, @kazemr et al, call for changes to global guidelines. https://t.co/U6O3GdtgZ2 2/2

Is raised #bloodpressure (BP) an inevitable and essential process of ageing is it time to remove #hypertension from our vocabulary and manage #CVD risk irrespective of an individual's BP into very old age? https://t.co/o7Ym5ZKrDZ https://t.co/6jDfXS06h8 #ESCCongress @TheLancet

So proud to have lectured today at #ESCCongress about SGLT2i! Thanks for the invitation, @escardio! Session: Meet the Experts: fuel up! – targeting cardiac energy metabolism in type 2 diabetes and HF… Title: ... By Pharmacological Interventions: SGLT2i in heart failure